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manual and fluoroscopic visual feedback as the catheter was withdrawn from the PV into
the left atrium. Real-time impedance was measured at the ostium, inside the PV at
approximately 1 and 3 cms from the ostium, in the left atrial appendage, and at the poste-
rior left atrial wall. There was an impedance gradient from the distal PV (127 ± 30 Ω) to
the proximal PV (108 ± 15 Ω) to the ostium (98 ± 11 Ω) in each PV (p<0.01). There were
no significant impedance difference between the ostial and left atrial sites. Impedance
was higher in the distal and proximal right inferior PV than in the other PVs (p<0.01).
Ostial impedance was similar among all PVs.
Conclusions: There is a significant impedance gradient from the left atrium to the distal
PV. Continuous monitoring of a rise in impedance during ostial ablation for PV isolation
may prevent inadvertent applications of RF energy within the PV and may minimize the
risk of PV stenosis.
1052-222 Thromboembolic Events in Patients Undergoing Atrial 
Fibrillation Ablation-Incidence, Timing, and Predictors
Mark E. Vanderhoff, Erica S. Zado, Edward P. Gerstenfeld, Sanjay Dixit, Hemal Nayak, 
Andrea M. Russo, David J. Callans, Francis E. Marchlinski, University of Pennsylvania 
Health System, Philadelphia, PA
BACKGROUND: Thromboembolic stroke (TES) remains a serious complication of pul-
monary vein (PV) isolation for atrial fibrillation (AF). We sought to determine the inci-
dence and risk factors associated with TES in a consecutive series of pts undergoing AF
ablation. METHODS: Between December 1999 and August 2003, 400 patients under-
went PV isolation. Lasso mapping catheter (LMC) was used to define PV ostium (os) and
RFA lesions using a 4 mm Navistar catheter (40 W, 52°C, 90 sec) were created proximal
to LMC poles showing earliest PV potentials (entry). Heparin was infused to maintain
activated clotting time (ACT) at >250 seconds and intracardiac echocardiographic moni-
toring (ACUNAVTM) was performed.
RESULTS: Four patients (1.0%; 3 males; age: 53±2 years) developed TES (sudden
onset new neurologic deficit). All TES events occurred in initial 6 hours after completion
of procedure following reversal of ACT with protamine bolus (mean dose 15±5 mg).
Three patients had complete neurologic recovery (two patients required tPA). Compari-
son between pts manifesting TES and those that did not is shown in the table. No patient
developed TES during the actual ablation procedure.
CONCLUSION: TES is infrequently observed in pts undergoing AF ablation and appears
most common in the early post ablation period. Pts with prior history of TES events are at
highest risk, 3 of 15 (20%). These data have important implications regarding patient
selection, counseling, and management prior to and following AF ablation procedure.
* p < 0.001
1052-223 Does Catheter Ablation of Atrial Fibrillation Alter 
Intrinsic Left Atrial Mechanical Function?
David Schwartzman, Raveen Bazaz, Doug Hettrick, University of Pittsburgh, Pittsburgh, 
PA, Medtronic, Inc., Minneapolis, MN
Background: The impact of left atrial (LA) catheter ablation on intrinsic global mechani-
cal function of the chamber is unclear. Methods: Seventeen patients (median data: age
56 yrs; LA 42 mm; EF 54%) underwent LA ablation in an effort to suppress atrial fibrilla-
tion. Radiofrequency energy, applied in the LA body, was targeted so as to "encircle" both
left and right pulmonary venous vestibules. In each patient this yielded ablation or electri-
cal isolation of the subtended myocardium. In each patient, instantaneous LA pressure
and volume (conductance) were measured simultaneously. Measurements were made
using a catheter placed into the LA body. Data was acquired immediately prior to and
after ablation. Analysis utilized multiple indices of LA pump and reservoir functions.
Results (table shows mean + standard deviation): 
Conclusions: Despite a large volume of ablated/isolated myocardium, ablation did not
significantly alter intrinsic global LA mechanical function. A significant impact on regional
function cannot be excluded.
1052-224 Pre-Existent Left Atrial Scarring in Patients Undergoing 
Pulmonary Vein Isolation: An Independent Predictor of 
Procedural Failure
Nassir Marrouche, Jennifer E. Cummings, Mandeep Bhargava, J. David Burkhardt, 
George Joseph, Yaariv Khaykin, Atul Verma, Ahmad Abdul-Karim, Walid Saliba, Robert 
Schweikert, Andrea Natale, The Cleveland Clinic Foundation, Cleveland, OH
Background:The goal of this study was to assess the impact of pre-existent left atrial
scarring on long-term procedural outcomes in patients undergoing pulmonary vein isola-
tion (PVI) for atrial fibrillation.
Methods: 613 patients presented for PVI for treatment of atrial fibrillation (AF). Prior to
each PVI procedure the left atrium (LA) was mapped using a multipolar Lasso catheter.
LA scar was defined as a voltage < 0.5 mV. Out of 613 patients scarring of the LA wall
was present in 31 patients. All PVs and the SVC were ablated in all study patients.
Results: The table below describes the outcomes in the 2 study groups.
Conclusion: Pre-existent left atrial scarring in patients undergoing pulmonary vein isola-
tion for treatment of symptomatic atrial fibrillation predicts long-term procedural failure. 
1052-225 Morphological Features of Marshall Ligament Tissue 
and Interatrial Septum in Patients With Repeated 
Pulmonary Vein Isolation: An Intracardiac 
Echocardiographic Imaging Study
Jian-Fang Ren, Francis E. Marchlinski, David J. Callans, University of Pennsylvania, 
Philadelphia, PA
Background: Morphology of the ligament of Marshall (LOM) and interatrial septum (IAS)
may be important features related to a successful isolation of left and right pulmonary
vein (PV) respectively. The aim of this study was to provide AcuNav ultrasound catheter
imaging measurements of LOM and IAS in pts with repeat radiofrequency (RF) ablation
for AF. Methods and Results: In 517 pts undergoing PV ostial isolation using 4 mm elec-
trode and RF (up to 40W, 52°C, 90sec), 76 (14.7%)(age 57±9 yrs) were required to
repeat (twice, n=8; triple and 4 times, one each) PV ablation for AF. The thickness of
LOM was measured at its cross-sectional view between left upper PV and LA appendage
and the length at an off-axis view between distal coronary sinus and left upper PV
ostium. The IAS thickness was measured at the area 5 mm adjacent to the fossa ovalis.
These measurements were compared to another age-matched 40 pts without repeat RF
for successful PV isolation with 6-month followup.(Table) The thickness of LOM and IAS
was greater in repeat RF pts than those without repeat RF (p<0.05). Higher echogenecity
of thickened LOM and lipomatous hypertrophy of IAS were more frequently observed in
repeat RF pts. Conclusion: Pts with repeat RF PV isolation had more thickening and
echogenecity of LOM and IAS at time of morphologic imaging. This is consistent with
more significant hypertrophy, fibosis or degeneration. Alternative or more effective RF
energy delivery tools may be required in pts with such findings to reduce need for repeat
procedures.
1052-226 Registration of Cardiac Computed Tomography Images 
With Three-Dimensional Electroanatomical Mapping to 
Guide Catheter Manipulation in the Left Atrium: 
Implications for Pulmonary Venous Isolation
Vivek Y. Reddy, Zachary Malchano, Petr Neuzil, Jiri Weichet, Jeremy N. Ruskin, 
Massachusetts General Hospital, Boston, MA, Na Homolce Hospital, Prague, Czech 
Republic
Background: 3D electroanatomical mapping (EAM) systems are frequently employed to
facilitate catheter ablation of atrial fibrillation (AF). Because of the complexity of the
chamber geometry, it is common to obtain preoperative CT/MRI to provide an anatomical
“roadmap” of the left atrium (LA) & pulmonary veins (PVs). In the optimal scenario, the
imaging dataset would be directly integrated and registered (i.e., properly aligned) with
the EAM system so as to guide real-time catheter movement within the LA and to the PV
ostia based on the actual chamber anatomy.
Methods: To determine the feasibility of this image integration paradigm to guide AF
catheter ablation, simulations were performed using a life-size model of the LA, PVs, and
aorta (Ao); the optimal means of achieving accurate registration between EAM data and
imaging data was determined. Based on these simulation results, the image integration
strategy was employed in a series of patients with AF (n=13) undergoing catheter abla-
tion to electrically isolate the PVs. For these patients, CT images of the LA-PVs were pre-
Lesions
(Total #)
Ablation Time (hours) History of prior embolic event
CVA
(n=4)
46
(+/- 8)
3.83
(+/- 1.77)
3
(75%)
No CVA
(n=396)
43
(+/- 8)
2.78
(+/- 1.37)
12
(3%) *
Pre-Ablation Post-Ablation P
    PUMP
Active Emptying Volume (cc) 11 + 18 8 + 7 0.3
A Loop Area (mmHg-cc) 43 + 88 43 + 105 0.9
End-Systolic Elastance Slope (mmHg/cc) 0.5 + 0.3 0.5 + 0.3 0.5
 RESERVOIR
Passive Emptying Volume (cc) 17 + 16 16 + 5 0.6
V Loop Area (mmHg-cc) 23 + 17 33 + 29 0.2
End-Reservoir Elastance  Slope (mmHg/cc) 1.3 + 1.1 1.1 + 0.8 0.8
LA scar No LA scar p value
Patients 31 582
Left atrial size 4.5±0.5 4.2±0.6 0.04
Structural heart disease 52% (16/31) 40% (232/528) 0.04
Ejection fraction 48±8% 54±6% 0.03
Recurrence of AF 46% (14/31) 14% (83/582) <0.0001
Repeat RF No Repeat RF
LOM(mm) Width Length IAS(mm) LOM(mm) Width Length IAS(mm)
Pre- 5.9±1.7 17.4±4.2 10.4±4.0 4.5±1.2 10.2±3.5 6.1±2.4
Post- 9.4±2.0 22.9±3.9
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operatively obtained, segmented, and reconstructed in 3D. During the procedure, the 3D
CT images, EAM data and real-time catheter position were imported into a custom work-
station. The electrophysiologist was blinded to these images, but the accuracy of the reg-
istration of these datasets was assessed prospectively by a second operator.
Results: Simulations were used to investigate 6 registration strategies employing a com-
bination of the descending Ao, PVs, and LA. The optimal strategy involved registering
points from both the Ao and LA; this resulted in an average distance from EA point to LA
image surface of 1.82 mm. To validate the in vivo registration, the catheter was localized
to the PV ostia on the registered CT image (confirmed by contrast injections under fluo-
roscopy). Also, after proper registration, the ridge between the LSPV and the LA append-
age was co-localized in both the CT and EAM datasets.
Conclusions: This study supports the feasibility of the general hypothesis that registra-
tion of pre-acquired cardiac images with real-time EA mapping can guide catheter move-
ment in the LA in a reliable and clinically-relevant manner.
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1053-209 Amiodarone in Survivors of Life-Threatening Ventricular 
Arrhythmias: Does It Improve Outcome? Results of the 
Leiden Out of Hospital Cardiac Arrest Trial (LOHCAT)
Philippine Kiès, Jeroen J. Bax, Alida E. Borger van der Burg, Eric Boersma, Marianne 
Bootsma, Lieselot van Erven, Ernst E. van der Wall, Martin J. Schalij, Leiden University 
Medical Center, Leiden, The Netherlands, Erasmus Medical Center, Rotterdam, The 
Netherlands
Introduction: Survivors of life-threatening ventricular arrhythmias (VA) are at increased
risk of death and recurrences. One-fourth of patients is discharged with amiodarone as
primary therapy or in addition to an implantable cardioverter defibrillator (ICD). The aim
of this study was to establish the effect of amiodarone on death and on the composite
endpoint of death and recurrences.
Methods: A total number of 417 consecutive survivors of life-threatening VA (328 male,
age 59±13 years) were included in a standardized screening and evaluation protocol to
determine the underlying pathology and optimise patient-tailored therapy. Multivariable
Cox’ regression analysis was performed to evaluate the relation between amiodarone
and survival and the composite endpoint of survival and recurrences. We adjusted for left
ventricular (LV) ejection fraction, LV dimensions, age, ischemic heart disease, inducibility
at electrophysiological test, revascularization, ICD and several other drugs.
Results: The majority of patients had ischemic heart disease (296, 71%). During follow-
up (32±25 months), 45 (10%) patients died (31 heart failure, 4 sudden death, 10 non-car-
diac). Amiodarone was administered in 110 (26%) patients, of whom 22 (20%) died, as
compared to 23 deaths (7.5%) in the patients without amiodarone (crude hazard ratio
(HR) 3.4, 95% CI 1.9-6, P<0.001). After adjustment for the previously mentioned vari-
ables, amiodarone still was associated with an increased risk on long-term mortality
(adjusted HR 3.7, 95% CI 1.1-12.6, P=0.03). Similar results were found for the composite
endpoint of death and/ or recurrences (crude HR 2.6, 95% CI 1.9-3.6, P<0.001 and
adjusted HR 1.9, 95% CI 1.1-3.2, P=0.03). Furthermore, this relation was found in
patients with and without ischemic heart disease.
Conclusion: Amiodarone may be associated with an increased risk of death (and recur-
rences), both in patients with and without ischemic heart disease. In view of these data, it
can be questioned whether amiodarone improves long-term outcome in survivors of life-
threatening VA.
1053-210 Incidence and Prognosis of Ventricular Tachycardia and 
Ventricular Fibrillation After Non-ST Elevation Acute 
Coronary Syndromes: Insights From the Global 
Registry of Acute Coronary Events
Álvaro Avezum, Marcos Knobel, Robert J. Goldberg, Immad Sadiq, Gordon Saperia, 
Tristam Smyth, Richard Paoloni, David Brieger, Polina Kuznetsova, Joel M. Gore, The 
GRACE Investigators, CTIA Hospital Albert Einstein, Sao Paulo, Brazil, University of 
Massachusetts Medical School, Worcester, MA
Background The incidence and prognosis of malignant ventricular arrhythmias (VA)
among patients with non-ST elevation acute coronary syndromes (NSTE-ACS) in clinical
practice is unknown. Most available data come from selected randomized clinical trials,
suggesting increased in-hospital and post-discharge mortality. The aim of this study was
to examine the incidence, predictors and outcomes of VA (ventricular tachycardia, ven-
tricular fibrillation and cardiac arrest) among patients with NSTE-ACS.
Methods We evaluated 17,545 patients with NSTE-ACS (non-ST elevation myocardial
infarction and unstable angina) from the Global Registry of Acute Coronary Events
(GRACE), and compared those who developed VA and increased hospital mortality to
those who did not. Adjustment for other risk factors related to increased mortality was
performed. Independent predictors of in-hospital VA were analyzed through multivariate
logistic regression modeling.
Results Presence of VA remained statistically significant after adjustment for demo-
graphics, treatment and clinical factors in a multivariate logistic model.
Conclusions In an unselected NSTE-ACS population from the observational GRACE
registry, the occurrence of in-hospital ventricular arrhythmic events was independently
associated with substantially higher in-hospital mortality. Prompt identification of predic-
tors of arrhythmic events and implementation of effective therapies are needed to
improve the survival of those patients. 
1053-211 A Multicenter Study of Depression as a Predictor for 
Appropriate Shocks Among Patients With Implantable 
Cardioverter Defibrillators
William Whang, Christine M. Albert, Rachel Lampert, Samuel F. Sears, Jr., Jamie B. 
Conti, Paul J. Wang, Jeremy N. Ruskin, James E. Muller, Murray A. Mittleman, 
Massachusetts General Hospital, Boston, MA
Background: Depression predicts mortality in patients with coronary artery disease
(CAD), but whether this is due to ventricular arrhythmia (VT/VF) is unknown.
Methods: To address this question, we prospectively examined the relationship between
baseline symptoms of depression and risk of VT/VF resulting in ICD discharge in the
Triggers of Ventricular Arrhythmias (TOVA) study. Symptoms were assessed by the Cen-
ter for Epidemiologic Studies-Depression (CES-D) scale. Scores of 16 to 27 and >27 rep-
resented mild and moderate to severe depression, respectively. Proportional hazards
models tested for associations among 1) all patients and 2) CAD patients, with adjust-
ment for prior shocks, age, sex, smoking, alcohol, hypertension, angina and CHF class,
and LVEF.
Results: Among 625 patients followed a median 186 days, 45 received ICD shocks for
VT/VF. Depression (CES-D score>16) was present in 111 (17.8%). Depression severity
was significantly related to VT/VF among all patients and among those in the CAD sub-
group (table). As compared to those without depression (CES-D score<16), the risk of
VT/VF was significantly elevated among patients with moderate to severe depression
(CES-D score>27), particularly among those with CAD who had a 7-fold increased risk of
VT/VF.
Conclusion: Depression severity predicts shocks for VT/VF among ICD patients. The
elevated risk of VT/VF may explain, at least in part, the higher cardiovascular mortality
observed in depressed patients, particularly those with CAD. 
1053-212 Temporal Patterns of Ventricular Tachyarrhythmia 
Recurrences Follow a Weibull Distribution
Mark Wood, Amy Xia, Xiaohong Zhou, Vasant Padmanabhan, Kenneth Ellenbogen, 
Medical College of Virginia, Richmond, VA, Medtronic, Inc., Minneapolis, MN
BACKGROUND: Understanding the temporal pattern of arrhythmias is essential to prop-
erly assess the response to antiarrhythmic therapies. Commonly used statistical mea-
sures usually assume a uniformly random pattern of tachyarrhythmias (VT) over time.
Table 1: Outcomes in NSTEMI/Unstable Angina Patients with Ventricular Arrhythmias
VT/VF CA VT/VF/
CA
No VT/VF/
CA
P value
Number of patients (% of 
total)
487 (2.8) 618 (3.6) 869 (5) 16,582 (95)
Death (%) 192 (40) 499 (81) 527 (61) 243 (2) <0.0001
OR 95% CI
In-hospital death (GRACE risk model) 75.0 59.1-94.5
VT, ventricular tachycardia; VF, ventricular fibrillation; CA, cardiac arrest
Table 2: Predictors of Ventricular Arrhythmia (Logistic Model)
OR 95% CI
In-hospital congestive heart failure 3.4 2.80-4.14
ST-segment deviation 1.4 1.16-1.61
Killip (per 1-class increase) 1.3 1.12-1.43
Pulse (per 30-bpm increase) 1.3 1.13-1.38
Initial serum creatinine (per 1-unit increase) 1.2 1.11-1.25
Initial cardiac enzymes 1.2 1.03-1.44
Age (per 10-year increase) 1.1 1.04-1.19
History of hypertension 0.8 0.69-0.96
Male 0.8 0.66-0.94
History of percutaneous coronary intervention 0.6 0.50-0.83
Hazard Ratios (95% CI) for VT/VF, Multivariable Analyses
All Patients
(n=625)
Patients with CAD
(n=465)
CES-D > 16 and < 27 1.58 (0.69 - 3.65) 1.96 (0.80 - 4.85)
CES-D > 27 4.06 (1.32 - 12.46) 7.55 (2.15 - 26.56)
P for trend 0.017 0.002
